Lupin's Aurangabad facility gets zero adverse observations in US FDA's latest inspection. 24 Apr 2024, . 11:33 AM ...

New Delhi: Drug firm Lupin on Monday said the US health regulator has completed inspection of its Aurangabad facility in Maharashtra without any observation. The inspection was carried out by the ...

Pharma major Lupin Ltd has received Establishment Inspection Report (EIR) from the US Food and Drug Administration for its Aurangabad facility. The inspection for the facility was carried out by ...

Lupin said its Aurangabad facility is involved in the manufacturing of oral solid dosage, oral liquid and powder for oral suspension products for the US Market, WHO/Global Institution markets and ...

April 3 (Reuters) - Lupin Ltd: April 3 (Reuters) - Lupin Ltd: Skip to main content. Exclusive news, data and analytics for financial market professionals Learn more about Refinitiv. World.

Drug firm Lupin today said the US health regulator has made eight observations after inspecting its Aurangabad facility in Maharashtra. The facility was recently inspected by the United States ...

July 31 (Reuters) - Lupin Ltd: July 31 (Reuters) - Lupin Ltd: Skip to main content. Exclusive news, data and analytics for financial market professionals Learn more about Refinitiv.

New Delhi, Aug 21 (PTI) Drug firm Lupin today said it has received establishment inspection report (EIR) from the US health regulator for its Aurangabad plant in Maharashtra.

Stocks News:Lupin’s Aurangabad facility under USFDA lens. Lupin’s Aurangabad facility under USFDA lens. SENSEX 77,414.92 -191.51. NIFTY 23,519.35 ...

New Delhi, Jul 31 (PTI) Drug major Lupin today said the US health regulator has completed the prior approval inspection (PAI) of its Aurangabad manufacturing plant.

The US Food and Drugs Administration (FDA) (USFDA) is set to begin inspection of Lupin's Aurangabad plant from April 17, reports CNBC-TV18’s Ekta Batra quoting sources.

Business News: New Delhi, Feb 17 () Drug firm Lupin on Monday said the US health regulator has completed inspection of its Aurangabad facility in Maharashtra without.